- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
NIH Environmental Health Chief Steps Aside
20 August 2007 (All day)
In an escalating controversy, David Schwartz, director of the National Institute of Health's (NIH's) environmental health institute, is stepping aside while NIH conducts a sweeping review of the $642-million-a-year institute.
Schwartz, a pulmonologist at Duke University, took the helm of the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, North Carolina, in May 2005. Senator Charles Grassley (R-IA) has recently raised ethics questions about Schwartz's management practices, including his consulting work for law firms, his use of guest researchers from Duke, and cost overruns in his laboratory budget (Science, 6 July, p. 26). Lawmakers have also questioned Schwartz's management of NIEHS's journal and the use of an outside contractor by the institute's National Toxicology Program. A memo that NIH Director Elias Zerhouni e-mailed today to the directors of NIH's 27 institutes and centers cites congressional concerns and says that Schwartz "has agreed to step aside" during a review of "specific issues raised to date" and topics such as governance, grants and contracts, financial management, and NIEHS's ethics program.
Schwartz sent an e-mail to staff that called the move "personally painful" but said he is "committed to a full and comprehensive review" of NIEHS's policies. Deputy director Samuel Wilson will serve as acting director, and Schwartz will continue as chief of his own lab at another NIH institute. Zerhouni expects the review to take several months.